\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ \\â\\€\\¢\\ vitals\\:\\ temp\\ 98\\.4\\ degf\\,\\ bp\\ 186\\/110\\,\\ hr\\ 136\\,\\ resps\\ 18\ \(0\)\
\-\ \\â\\€\\¢\\ general\\:\\ ao\\ x\\ 3\ \(0\)\
\-\ \\â\\€\\¢\\ heart\\:\\ regular\\,\\ but\\ tachy\\ \ \(0\)\
\-\ \\â\\€\\¢\\ lungs\\:\\ ctab\ \(0\)\
\-\ \\â\\€\\¢\\ abdomen\\:\\ soft\\,\\ non\\-tender\\,\\ normoactive\\ bs\\ x4\ \(0\)\
\-\ \\â\\€\\¢\\ ext\\:\\ varus\\ deformity\\ over\\ suspected\\ fx\\ \ \(0\)\
\-\ laboratory\\:\ \(3\)\
\-\ \\â\\€\\¢\\ wbc\\:\\ 13\\.7\\ \\(high\\)\ \(0\)\
\-\ \\â\\€\\¢\\ basic\\ metabolic\\ panel\\:\\ wnl\ \(0\)\
\-\ \\â\\€\\¢\\ cardiac\\ enzymes\\:\\ negative\ \(0\)\
\-\ \\â\\€\\¢\\ pt\\ and\\ inr\\:\\ wnl\ \(0\)\
\-\ intramedulary\\ nail\\ placed\\ in\\ both\\ femurs\\.\\ pt\\.\\ receiving\\ radiation\\ therapy\\ for\\ extensive\\ bone\\ mets\\ in\\ the\\ hips\\.\\ she\\ has\\ been\\ started\\ on\\ chemotherapy\\ to\\ reduce\\ size\\ of\\ breast\\ lesion\\ with\\ the\\ ultimate\\ goal\\ of\\ resection\\.\ \(0\)\
\-\ \\â\\€\\¢\\ right\\ hip\\ and\\ pelvis\\ radiographs\ \(0\)\
\-\ 1\\)\\ within\\ the\\ subtrochanteric\\ region\\ of\\ the\\ right\\ femur\\,\\ there\\ is\\ a\\ lucent\\ slightly\\ expansile\\ lesion\\ with\\ sclerotic\\ margins\\.\\ a\\ pathologic\\ fracture\\ is\\ evident\\ through\\ the\\ lesion\\.\ \(0\)\
\-\ 2\\)\\ proximal\\ left\\ hip\\ shows\\ a\\ lucent\\ lesion\\.\ \(0\)\
\-\ \\â\\€\\¢\\ chest\\ radiograph\ \(0\)\
\-\ 1\\)\\ there\\ \\ is\\ \\ a\\ \\ large\\ \\ mass\\ \\ in\\ \\ the\\ \\ left\\ \\ breast\\ \\ along\\ \\ with\\ \\ marked\\ \\ swelling\\ \\ in\\ \\ the\\ \\ left\\ \\ axillary\\ \\ region\\.\ \(0\)\
\-\ ct\\ chest\\ \ \(2\)\
\-\ 1\\)\\ large\\ mass\\ centered\\ in\\ the\\ patient\\'s\\ left\\ breast\\ measuring\\ approximately\\ 16\\.2\\ x\\ 11\\.1\\ cm\\ in\\ cross\\-section\\.\ \(1\)\
\-\ 2\\)\\ axillary\\ adenopathy\\ measuring\\ approximately\\ 6\\.1\\ x\\ 6\\.0\\ cm\\.\ \(0\)\
\-\ pathologic\\ fracture\\,\\ metastatic\\ disease\ \(0\)\
\-\ 1\\)\\ metatstatic\\ lesions\\,\\ breast\\ cancer\\ primary\ \(0\)\
\-\ 2\\)\\ multiple\\ myeloma\\,\\ plasmacytoma\\ in\\ breast\ \(0\)\
\-\ this\\ 64\\ y\\.o\\.\\ woman\\ slipped\\ on\\ her\\ bathroom\\ floor\\ at\\ home\\ and\\ fell\\ on\\ her\\ right\\ side\\.\\ \\ \\ she\\ reports\\ 10\\/10\\ pain\\ on\\ the\\ right\\ side\\,\\ radiating\\ down\\ her\\ right\\ lower\\ extremity\\.\\ \\ \\ pt\\.\\ denied\\ cp\\,\\ sob\\,\\ or\\ loc\\.\\ she\\ also\\ acknowledges\\ a\\ left\\ breast\\ mass\\,\\ present\\ for\\ two\\ years\\;\\ and\\,\\ a\\ significant\\ weight\\ loss\\ over\\ the\\ past\\ 4\\ months\\.\ \(0\)\
\-\ epithelial\\ malignancies\\ of\\ the\\ breast\\ are\\ the\\ most\\ common\\ form\\ of\\ non\\-skin\\ cancers\\ in\\ females\\ and\\ account\\ for\\ about\\ one\\-third\\ of\\ all\\ cancers\\ in\\ women\\.\\ it\\ is\\ second\\ only\\ to\\ lung\\ cancer\\ as\\ the\\ most\\ common\\ cause\\ of\\ death\\.\\ \ \(0\)\
\-\ risk\\ factors\\ for\\ the\\ development\\ of\\ breast\\ cancer\\ include\\ a\\ family\\ history\\ \\(including\\ brca\\ gene\\)\\,\\ nulliparity\\,\\ and\\ first\\ pregnancy\\ past\\ the\\ age\\ of\\ 35\\.\\ early\\ menarche\\ or\\ late\\ menopause\\ are\\ believed\\ to\\ slightly\\ increase\\ risk\\.\\ seventy\\-five\\ percent\\ of\\ women\\,\\ however\\,\\ have\\ no\\ known\\ identifiable\\ risk\\ factors\\.\\ \ \(0\)\
\-\ breast\\ cancer\\ screening\\ by\\ way\\ of\\ mammography\\ has\\ been\\ proven\\ to\\ decrease\\ mortality\\ \\/\\ increase\\ survival\\.\\ routine\\ annual\\ mammography\\ is\\ recommended\\ for\\ women\\ over\\ the\\ age\\ of\\ 40\\.\\ when\\ symptomatic\\,\\ a\\ diagnostic\\ breast\\ imaging\\ workup\\ must\\ ensure\\.\\ \\ the\\ presenting\\ complaint\\ \\(in\\ approximately\\ 70\\%\\ of\\ diagnostic\\ cases\\)\\ is\\ breast\\ pain\\ with\\ an\\ associated\\ lump\\.\\ back\\ or\\ bone\\ pain\\,\\ jaundice\\,\\ or\\ weight\\ loss\\ are\\ worrisome\\ systemic\\ symptoms\\ that\\ may\\ be\\ caused\\ by\\ metastatses\\,\\ but\\ are\\ rarely\\ the\\ initial\\ complaint\\.\\ \\(1\\)\ \(0\)\
\-\ infiltrating\\ ductal\\ carcinoma\\ is\\ one\\ of\\ the\\ more\\ common\\ diagnoses\\,\\ and\\ when\\ metastatic\\ disease\\ ensues\\ it\\ most\\ commonly\\ involve\\ the\\ lungs\\,\\ pleura\\,\\ liver\\,\\ and\\ brain\\.\\ infiltrating\\ lobular\\ carcinoma\\ may\\ metastatize\\ to\\ unusual\\ sites\\ such\\ as\\ the\\ bone\\ marrow\\,\\ meninges\\,\\ peritoneum\\,\\ and\\ retroperitoneal\\ structures\\,\\ such\\ as\\ the\\ ureters\\.\\ \\(2\\)\ \(0\)\
\-\ treatment\\ typically\\ consists\\ of\\ surgical\\ removal\\ of\\ the\\ breast\\ mass\\ via\\ either\\ lumpectomy\\ or\\ mastectomy\\,\\ axillary\\ sentinel\\ lymph\\ node\\ biopsy\\,\\ and\\ post\\-op\\ radiation\\/chemotherapy\\ to\\ reduce\\ risk\\ of\\ recurrence\\.\\ the\\ most\\ important\\ prognostic\\ factors\\ are\\ the\\ size\\ of\\ the\\ original\\ tumor\\ and\\ amount\\ of\\ axillary\\ lymph\\ node\\ involvement\\.\\ \\(3\\)\ \(0\)\
\-\ \\[1\\]\\:\\ giuliano\\ armando\\ e\\,\\ hurvitz\\ sara\\ a\\,\\ \\"chapter\\ 17\\.\\ breast\\ disorders\\"\\ \\(chapter\\)\\.\\ mcphee\\ sj\\,\\ papadakis\\ ma\\:\\ current\\ medical\\ diagnosis\\ \\&\\ treatment\\ 2011\\:\\ http\\:\\/\\/0\\-www\\.accessmedicine\\.com\\.carlson\\.utoledo\\.edu\\/content\\.aspx\\?aid\\=8538\\.\ \(0\)\
\-\ \\[2\\]\\:\\ phan\\ alexandria\\ t\\,\\ hennessy\\ bryan\\ t\\,\\ valero\\ vicente\\,\\ \\"chapter\\ 20\\.\\ metastatic\\ breast\\ cancer\\"\\ \\(chapter\\)\\.\\ kantarjian\\ hm\\,\\ wolff\\ ra\\,\\ koller\\ ca\\:\\ md\\ anderson\\ manual\\ of\\ medical\\ oncology\\:\\ http\\:\\/\\/0\\-www\\.accessmedicine\\.com\\.carlson\\.utoledo\\.edu\\/content\\.aspx\\?aid\\=2791693\\.\ \(0\)\
\-\ \\[3\\]\\:\\ lippman\\ marc\\ e\\,\\ \\"chapter\\ 86\\.\\ breast\\ cancer\\"\\ \\(chapter\\)\\.\\ fauci\\ as\\,\\ braunwald\\ e\\,\\ kasper\\ dl\\,\\ hauser\\ sl\\,\\ longo\\ dl\\,\\ jameson\\ jl\\,\\ loscalzo\\ j\\:\\ harrison\\'s\\ principles\\ of\\ internal\\ medicine\\,\\ 17e\\:\\ http\\:\\/\\/0\\-www\\.accessmedicine\\.com\\.carlson\\.utoledo\\.edu\\/content\\.aspx\\?aid\\=2877884\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.3744436106232143\ \(0\)\
\-\ chapter\\:\\ 0\\.2569947754876653\ \(0\)\
\-\ the\\:\\ 0\\.17834107885103084\ \(0\)\
\-\ of\\:\\ 0\\.14127215388105788\ \(0\)\
\-\ cancer\\:\\ 0\\.1373813733998914\ \(0\)\
\-\ axillary\\:\\ 0\\.13525312656718974\ \(0\)\
\-\ risk\\:\\ 0\\.09824937167766334\ \(0\)\
\-\ women\\:\\ 0\\.09280831383014933\ \(0\)\
\-\ factors\\:\\ 0\\.08723458617289537\ \(0\)\
\-\ in\\:\\ 0\\.08551651435034353\ \(0\)\
\-\ and\\:\\ 0\\.07813734190299505\ \(0\)\
\-\ http\\:\\ 0\\.07624285009020498\ \(0\)\
\-\ pt\\:\\ 0\\.07421792975795284\ \(0\)\
\-\ cancers\\:\\ 0\\.0738434287308789\ \(0\)\
\-\ mammography\\:\\ 0\\.07164598852766382\ \(0\)\
\-\ most\\:\\ 0\\.07156139836850109\ \(0\)\
\-\ reduce\\:\\ 0\\.0700052482988494\ \(0\)\
\-\ infiltrating\\:\\ 0\\.06744800367884587\ \(0\)\
\-\ lucent\\:\\ 0\\.0664288712888032\ \(0\)\
\-\ lesion\\:\\ 0\\.06592261736169283\ \(0\)\
\-\ is\\:\\ 0\\.06589884890291407\ \(0\)\
\-\ approximately\\:\\ 0\\.06580331487479907\ \(0\)\
\-\ are\\:\\ 0\\.06522078234223248\ \(0\)\
\-\ wnl\\:\\ 0\\.06447824966737521\ \(0\)\
\-\ her\\:\\ 0\\.06442866192596983\ \(0\)\
\-\ dl\\:\\ 0\\.061541981635021066\ \(0\)\
\-\ she\\:\\ 0\\.06138977261520384\ \(0\)\
\-\ or\\:\\ 0\\.059794119238836874\ \(0\)\
\-\ complaint\\:\\ 0\\.05954526988907633\ \(0\)\
\-\ node\\:\\ 0\\.05909381063611671\ \(0\)\
\-\ left\\:\\ 0\\.058632142019540236\ \(0\)\
\-\ common\\:\\ 0\\.058485513378551575\ \(0\)\
\-\ over\\:\\ 0\\.05734382453512072\ \(0\)\
\-\ right\\:\\ 0\\.05698545347539627\ \(0\)\
\-\ metastatic\\:\\ 0\\.05656066999317482\ \(0\)\
\-\ pathologic\\:\\ 0\\.056333671523240966\ \(0\)\
\-\ bone\\:\\ 0\\.056269971360121775\ \(0\)\
\-\ as\\:\\ 0\\.05524035493583664\ \(0\)\
\-\ increase\\:\\ 0\\.05519134976972715\ \(0\)\
\-\ degf\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ resps\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ nulliparity\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ metastatize\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ giuliano\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ armando\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ hurvitz\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ sara\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ phan\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ alexandria\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ hennessy\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ bryan\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ valero\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ vicente\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ kantarjian\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ wolff\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ koller\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ lippman\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ kasper\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ longo\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ loscalzo\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ 17e\\:\\ 0\\.05497482517618131\ \(0\)\
\-\ slightly\\:\\ 0\\.05363013375678181\ \(0\)\
\-\ lymph\\:\\ 0\\.053462346088218135\ \(0\)\
\-\ measuring\\:\\ 0\\.05318778859229191\ \(0\)\
\-\ hip\\:\\ 0\\.05281362164803617\ \(0\)\
\-\ acknowledges\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ brca\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ menopause\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ metastatses\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ ensues\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ hm\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ marc\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ fauci\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ braunwald\\:\\ 0\\.052531380349290245\ \(0\)\
\-\ mass\\:\\ 0\\.05252296955821107\ \(0\)\
\-\ diagnostic\\:\\ 0\\.05239975942926927\ \(0\)\
\-\ for\\:\\ 0\\.05209562022141076\ \(0\)\
\-\ to\\:\\ 0\\.05156370505971795\ \(0\)\
\-\ tachy\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ intramedulary\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ subtrochanteric\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ metatstatic\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ mcphee\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ papadakis\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ hauser\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ jameson\\:\\ 0\\.05079772865481673\ \(0\)\
\-\ lungs\\:\\ 0\\.05073961759338754\ \(0\)\
\-\ bathroom\\:\\ 0\\.0494530039295332\ \(0\)\
\-\ menarche\\:\\ 0\\.0494530039295332\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.04881857280366951\ \(0\)\
\-\ ao\\:\\ 0\\.04835428382792566\ \(0\)\
\-\ jl\\:\\ 0\\.04835428382792566\ \(0\)\
\-\ harrison\\:\\ 0\\.04835428382792566\ \(0\)\
\-\ weight\\:\\ 0\\.04794428852011643\ \(0\)\
\-\ side\\:\\ 0\\.0474959301340853\ \(0\)\
\-\ nail\\:\\ 0\\.04742532921838334\ \(0\)\
\-\ principles\\:\\ 0\\.04662063213345215\ \(0\)\
\-\ size\\:\\ 0\\.046552063340524266\ \(0\)\
\-\ ultimate\\:\\ 0\\.04591083900103459\ \(0\)\
\-\ sj\\:\\ 0\\.04591083900103459\ \(0\)\
\-\ radiation\\:\\ 0\\.0455608843133174\ \(0\)\
\-\ x4\\:\\ 0\\.04527590740816862\ \(0\)\
\-\ anderson\\:\\ 0\\.04527590740816862\ \(0\)\
\-\ sl\\:\\ 0\\.04527590740816862\ \(0\)\
\-\ past\\:\\ 0\\.04475243327064608\ \(0\)\
\-\ such\\:\\ 0\\.04422488503986908\ \(0\)\
\-\ worrisome\\:\\ 0\\.044177187306561075\ \(0\)\
\-\ medical\\:\\ 0\\.04369473966318232\ \(0\)\
\-\ sentinel\\:\\ 0\\.04324823269701875\ \(0\)\
\-\ age\\:\\ 0\\.043163278489038344\ \(0\)\
\-\ loc\\:\\ 0\\.04283246258127755\ \(0\)\
\-\ cp\\:\\ 0\\.04207819488215211\ \(0\)\
\-\ loss\\:\\ 0\\.04188632765072145\ \(0\)\
\-\ normoactive\\:\\ 0\\.04173374247967001\ \(0\)\
\-\ meninges\\:\\ 0\\.04173374247967001\ \(0\)\
\-\ when\\:\\ 0\\.041530275001394716\ \(0\)\
\-\ on\\:\\ 0\\.04152865697868535\ \(0\)\
\-\ 136\\:\\ 0\\.04140791845813179\ \(0\)\
\-\ region\\:\\ 0\\.041124426795906055\ \(0\)\
\-\ carcinoma\\:\\ 0\\.041124426795906055\ \(0\)\
\-\ femurs\\:\\ 0\\.04109881088680403\ \(0\)\
\-\ ma\\:\\ 0\\.04109881088680403\ \(0\)\
\-\ fx\\:\\ 0\\.04080478787012769\ \(0\)\
\-\ plasmacytoma\\:\\ 0\\.04080478787012769\ \(0\)\
\-\ identifiable\\:\\ 0\\.04052444539607281\ \(0\)\
\-\ peritoneum\\:\\ 0\\.04052444539607281\ \(0\)\
\-\ gene\\:\\ 0\\.04025656678672298\ \(0\)\
\-\ prognostic\\:\\ 0\\.04025656678672298\ \(0\)\
\-\ been\\:\\ 0\\.04005577951687975\ \(0\)\
\-\ manual\\:\\ 0\\.04000009078519649\ \(0\)\
\-\ lumpectomy\\:\\ 0\\.039754086161520506\ \(0\)\
\-\ cm\\:\\ 0\\.03948513789503285\ \(0\)\
\-\ one\\:\\ 0\\.039363831522182584\ \(0\)\
\-\ enzymes\\:\\ 0\\.039290297652778944\ \(0\)\
\-\ fracture\\:\\ 0\\.03907421561014563\ \(0\)\
\-\ varus\\:\\ 0\\.03907113617565417\ \(0\)\
\-\ goal\\:\\ 0\\.03907113617565417\ \(0\)\
\-\ basic\\:\\ 0\\.03865536605991297\ \(0\)\
\-\ malignancies\\:\\ 0\\.03865536605991297\ \(0\)\
\-\ slipped\\:\\ 0\\.038457765523271625\ \(0\)\
\-\ ctab\\:\\ 0\\.037726411450370645\ \(0\)\
\-\ ureters\\:\\ 0\\.03739153216576619\ \(0\)\
\-\ 2011\\:\\ 0\\.037074286475123744\ \(0\)\
\-\ epithelial\\:\\ 0\\.03692171436543945\ \(0\)\
\-\ pain\\:\\ 0\\.036903072519788284\ \(0\)\
\-\ ext\\:\\ 0\\.03677290985602585\ \(0\)\
\-\ inr\\:\\ 0\\.03677290985602585\ \(0\)\
\-\ believed\\:\\ 0\\.03677290985602585\ \(0\)\
\-\ oncology\\:\\ 0\\.03677290985602585\ \(0\)\
\-\ jaundice\\:\\ 0\\.0366276913487631\ \(0\)\
\-\ pleura\\:\\ 0\\.0366276913487631\ \(0\)\
\-\ mastectomy\\:\\ 0\\.03648589006667652\ \(0\)\
\-\ original\\:\\ 0\\.03648589006667652\ \(0\)\
\-\ diagnoses\\:\\ 0\\.036347348874708224\ \(0\)\
\-\ chest\\:\\ 0\\.036290867109105514\ \(0\)\
\-\ hips\\:\\ 0\\.036211921233021895\ \(0\)\
\-\ panel\\:\\ 0\\.0360794702653584\ \(0\)\
\-\ way\\:\\ 0\\.03594986792759274\ \(0\)\
\-\ lump\\:\\ 0\\.03594986792759274\ \(0\)\
\-\ centered\\:\\ 0\\.03582299426383191\ \(0\)\
\-\ ensure\\:\\ 0\\.03582299426383191\ \(0\)\
\-\ receiving\\:\\ 0\\.03569873673922078\ \(0\)\
\-\ myeloma\\:\\ 0\\.03569873673922078\ \(0\)\
\-\ bs\\:\\ 0\\.035576989640155925\ \(0\)\
\-\ sob\\:\\ 0\\.035576989640155925\ \(0\)\
\-\ mets\\:\\ 0\\.035340634780650235\ \(0\)\
\-\ it\\:\\ 0\\.035193263082472254\ \(0\)\
\-\ account\\:\\ 0\\.0350026241494247\ \(0\)\
\-\ lobular\\:\\ 0\\.03489403965428959\ \(0\)\
\-\ floor\\:\\ 0\\.03478737710987614\ \(0\)\
\-\ proven\\:\\ 0\\.03468256966057867\ \(0\)\
\-\ may\\:\\ 0\\.03459824824125071\ \(0\)\
\-\ females\\:\\ 0\\.034579553879627\ \(0\)\
\-\ large\\:\\ 0\\.03444823846623361\ \(0\)\
\-\ consists\\:\\ 0\\.034184246521872026\ \(0\)\
\-\ temp\\:\\ 0\\.034089342569358395\ \(0\)\
\-\ but\\:\\ 0\\.033998044099516185\ \(0\)\
\-\ percent\\:\\ 0\\.0339959100553667\ \(0\)\
\-\ ra\\:\\ 0\\.0339959100553667\ \(0\)\
\-\ mortality\\:\\ 0\\.033813281641797435\ \(0\)\
\-\ death\\:\\ 0\\.03372400183942294\ \(0\)\
\-\ survival\\:\\ 0\\.033549314929006056\ \(0\)\
\-\ sites\\:\\ 0\\.033549314929006056\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.03313354481326485\ \(0\)\
\-\ radiating\\:\\ 0\\.03305372541540263\ \(0\)\
\-\ treatment\\:\\ 0\\.03275029569590321\ \(0\)\
\-\ late\\:\\ 0\\.03245059482739852\ \(0\)\
\-\ workup\\:\\ 0\\.03237927711413941\ \(0\)\
\-\ 64\\:\\ 0\\.03230879354531194\ \(0\)\
\-\ annual\\:\\ 0\\.031772771406228154\ \(0\)\
\-\ has\\:\\ 0\\.031403977455323376\ \(0\)\
\-\ md\\:\\ 0\\.03133992967443365\ \(0\)\
\-\ metabolic\\:\\ 0\\.031163538259285646\ \(0\)\
\-\ expansile\\:\\ 0\\.031105870102114987\ \(0\)\
\-\ denied\\:\\ 0\\.031048748570772326\ \(0\)\
\-\ unusual\\:\\ 0\\.030825527628060113\ \(0\)\
\-\ rarely\\:\\ 0\\.0306633758785575\ \(0\)\
\-\ fell\\:\\ 0\\.030610280588511556\ \(0\)\
\-\ systemic\\:\\ 0\\.030505473139214086\ \(0\)\
\-\ home\\:\\ 0\\.03040245735826242\ \(0\)\
\-\ vitals\\:\\ 0\\.030351602402989546\ \(0\)\
\-\ disorders\\:\\ 0\\.030351602402989546\ \(0\)\
\-\ medicine\\:\\ 0\\.030301173017183797\ \(0\)\
\-\ ductal\\:\\ 0\\.030251162137328886\ \(0\)\
\-\ involve\\:\\ 0\\.030251162137328886\ \(0\)\
\-\ current\\:\\ 0\\.03010357248054246\ \(0\)\
\-\ form\\:\\ 0\\.03005516839350781\ \(0\)\
\-\ regular\\:\\ 0\\.029681325978969227\ \(0\)\
\-\ hr\\:\\ 0\\.029546905318058356\ \(0\)\
\-\ evident\\:\\ 0\\.029546905318058356\ \(0\)\
\-\ decrease\\:\\ 0\\.029546905318058356\ \(0\)\
\-\ must\\:\\ 0\\.02945892891710274\ \(0\)\
\-\ margins\\:\\ 0\\.029329326579337088\ \(0\)\
\-\ ca\\:\\ 0\\.029329326579337088\ \(0\)\
\-\ by\\:\\ 0\\.02919614903868262\ \(0\)\
\-\ important\\:\\ 0\\.02911933054342652\ \(0\)\
\-\ started\\:\\ 0\\.028956448291900267\ \(0\)\
\-\ adenopathy\\:\\ 0\\.028916406440682198\ \(0\)\
\-\ disease\\:\\ 0\\.02885970884899748\ \(0\)\
\-\ sclerotic\\:\\ 0\\.0288371121856408\ \(0\)\
\-\ marrow\\:\\ 0\\.02856752132271028\ \(0\)\
\-\ development\\:\\ 0\\.02841871681329668\ \(0\)\
\-\ either\\:\\ 0\\.02841871681329668\ \(0\)\
\-\ 70\\:\\ 0\\.028382082801169047\ \(0\)\
\-\ recurrence\\:\\ 0\\.028382082801169047\ \(0\)\
\-\ femur\\:\\ 0\\.028202180592774826\ \(0\)\
\-\ suspected\\:\\ 0\\.028166835761620483\ \(0\)\
\-\ pregnancy\\:\\ 0\\.028131697023947348\ \(0\)\
\-\ deformity\\:\\ 0\\.028096761990245595\ \(0\)\
\-\ via\\:\\ 0\\.028096761990245595\ \(0\)\
\-\ down\\:\\ 0\\.02792506158840723\ \(0\)\
\-\ screening\\:\\ 0\\.02792506158840723\ \(0\)\
\-\ bp\\:\\ 0\\.027891300847801982\ \(0\)\
\-\ general\\:\\ 0\\.027595674884863575\ \(0\)\
\-\ caused\\:\\ 0\\.02756370517361638\ \(0\)\
\-\ amount\\:\\ 0\\.027500270099070055\ \(0\)\
\-\ there\\:\\ 0\\.027356265899485453\ \(0\)\
\-\ recommended\\:\\ 0\\.02734454369649161\ \(0\)\
\-\ family\\:\\ 0\\.027044667083981833\ \(0\)\
\-\ presenting\\:\\ 0\\.02692877358075041\ \(0\)\
\-\ with\\:\\ 0\\.026925059801778766\ \(0\)\
\-\ placed\\:\\ 0\\.026786972298663822\ \(0\)\
\-\ reports\\:\\ 0\\.026731173044109068\ \(0\)\
\-\ routine\\:\\ 0\\.02662110100798561\ \(0\)\
\-\ extensive\\:\\ 0\\.026486279357192916\ \(0\)\
\-\ symptomatic\\:\\ 0\\.02643318406714697\ \(0\)\
\-\ removal\\:\\ 0\\.02627664860550351\ \(0\)\
\-\ 18\\:\\ 0\\.026049214956267636\ \(0\)\
\-\ marked\\:\\ 0\\.02599981897120808\ \(0\)\
\-\ structures\\:\\ 0\\.025830053479142866\ \(0\)\
\-\ about\\:\\ 0\\.025735149526629232\ \(0\)\
\-\ second\\:\\ 0\\.025735149526629232\ \(0\)\
\-\ cardiac\\:\\ 0\\.025526927324124215\ \(0\)\
\-\ commonly\\:\\ 0\\.02543664434058546\ \(0\)\
\-\ laboratory\\:\\ 0\\.024962907374880952\ \(0\)\
\-\ involvement\\:\\ 0\\.024880636111614306\ \(0\)\
\-\ early\\:\\ 0\\.024779351770535682\ \(0\)\
\-\ extremity\\:\\ 0\\.024759297587513957\ \(0\)\
\-\ including\\:\\ 0\\.024601222257090768\ \(0\)\
\-\ wbc\\:\\ 0\\.024296992287354005\ \(0\)\
\-\ typically\\:\\ 0\\.024132379661303206\ \(0\)\
\-\ biopsy\\:\\ 0\\.02409640178466935\ \(0\)\
\-\ pelvis\\:\\ 0\\.024042834530301847\ \(0\)\
\-\ heart\\:\\ 0\\.023902273605621454\ \(0\)\
\-\ liver\\:\\ 0\\.0237142043264374\ \(0\)\
\-\ cause\\:\\ 0\\.023418578363498987\ \(0\)\
\-\ first\\:\\ 0\\.02319827218574647\ \(0\)\
\-\ internal\\:\\ 0\\.023167447175127025\ \(0\)\
\-\ swelling\\:\\ 0\\.023136779035469488\ \(0\)\
\-\ cases\\:\\ 0\\.023121503294877593\ \(0\)\
\-\ initial\\:\\ 0\\.023060784630713576\ \(0\)\
\-\ along\\:\\ 0\\.023030653185756193\ \(0\)\
\-\ back\\:\\ 0\\.0229263639698027\ \(0\)\
\-\ radiograph\\:\\ 0\\.02238971334071088\ \(0\)\
\-\ radiographs\\:\\ 0\\.02229586509242654\ \(0\)\
\-\ known\\:\\ 0\\.022256087545782385\ \(0\)\
\-\ resection\\:\\ 0\\.02203551028656801\ \(0\)\
\-\ proximal\\:\\ 0\\.02147622064198994\ \(0\)\
\-\ only\\:\\ 0\\.02147622064198994\ \(0\)\
\-\ brain\\:\\ 0\\.02142995341712733\ \(0\)\
\-\ negative\\:\\ 0\\.02128199207770368\ \(0\)\
\-\ primary\\:\\ 0\\.021137576699173606\ \(0\)\
\-\ years\\:\\ 0\\.02107207304949784\ \(0\)\
\-\ abdomen\\:\\ 0\\.02097513353660792\ \(0\)\
\-\ lung\\:\\ 0\\.020911362820498856\ \(0\)\
\-\ through\\:\\ 0\\.02046325753840128\ \(0\)\
\-\ all\\:\\ 0\\.02046325753840128\ \(0\)\
\-\ include\\:\\ 0\\.020453450739757496\ \(0\)\
\-\ two\\:\\ 0\\.020414382360221806\ \(0\)\
\-\ however\\:\\ 0\\.020346616288612236\ \(0\)\
\-\ shows\\:\\ 0\\.020175781264831247\ \(0\)\
\-\ months\\:\\ 0\\.020009655927776555\ \(0\)\
\-\ significant\\:\\ 0\\.01984798755004566\ \(0\)\
\-\ therapy\\:\\ 0\\.019751283737808423\ \(0\)\
\-\ lesions\\:\\ 0\\.019742568947516425\ \(0\)\
\-\ high\\:\\ 0\\.019537107805072815\ \(0\)\
\-\ both\\:\\ 0\\.01916978702700498\ \(0\)\
\-\ more\\:\\ 0\\.01887614111219895\ \(0\)\
\-\ symptoms\\:\\ 0\\.018808640110339895\ \(0\)\
\-\ physical\\:\\ 0\\.018639496172237036\ \(0\)\
\-\ soft\\:\\ 0\\.018301089999254495\ \(0\)\
\-\ associated\\:\\ 0\\.018118768571061955\ \(0\)\
\-\ imaging\\:\\ 0\\.018065789975465953\ \(0\)\
\-\ tumor\\:\\ 0\\.017980680908835114\ \(0\)\
\-\ woman\\:\\ 0\\.017903171461721167\ \(0\)\
\-\ diagnosis\\:\\ 0\\.017820312838895794\ \(0\)\
\-\ present\\:\\ 0\\.01763947980205459\ \(0\)\
\-\ lower\\:\\ 0\\.017566211100885486\ \(0\)\
\-\ exam\\:\\ 0\\.017304932580291123\ \(0\)\
\-\ have\\:\\ 0\\.017172734281395048\ \(0\)\
\-\ multiple\\:\\ 0\\.0168140856969965\ \(0\)\
\-\ surgical\\:\\ 0\\.01670789305600539\ \(0\)\
\-\ also\\:\\ 0\\.01616951976724765\ \(0\)\
\-\ within\\:\\ 0\\.015832559406411973\ \(0\)\
\-\ that\\:\\ 0\\.01491792673097451\ \(0\)\
\-\ be\\:\\ 0\\.013944998727362136\ \(0\)\
\-\ an\\:\\ 0\\.013145295104755067\ \(0\)\
\-\ history\\:\\ 0\\.013133650122509876\ \(0\)\
\-\ ct\\:\\ 0\\.013087293921338198\ \(0\)\
\-\ at\\:\\ 0\\.012984278140386529\ \(0\)\
\-\ this\\:\\ 0\\.011812237907679\ \(0\)\
\-\ patient\\:\\ 0\\.011180810982801706\ \(0\)\
\-\ no\\:\\ 0\\.011178707937435159\ \(0\)\
